argenx SE (ARGX) stock
Close on Nov 12, 2026Market cap –P/E 50.1Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- 50.1
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- $1.29B
- EPS, diluted
- $19.57
- Free cash flow
- $679.03M
Trading
- Previous close
- $977.58
- Open
- $976.89
- Day's range
- $964.86 – $988.89
- Volume
- 449,423
- Average volume (20 days)
- 420,198
- Beta (5 years)
- 0.44
- 52-week range
- $661.85 – $1072.75
- RSI (14 days)
- 64.2
- Volatility (1 year)
- 37.7%
- Relative volume
- 1.31×
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ARGX | S&P 500 | Difference | ARGX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +20.8% | -2.7% | +23.5 pts | ||
| 3 months | +12.0% | -1.7% | +13.8 pts | ||
| Year to date | +16.7% | +11.9% | +4.8 pts | ||
| 1 year | +10.3% | +12.0% | −1.7 pts | ||
| 3 years | +100.6% | +78.2% | +22.5 pts | +26.1% | +21.2% |
| 5 years | +216.9% | +73.2% | +143.7 pts | +25.9% | +11.6% |
Eleven years at a glance
Fiscal years 2015 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases argenx filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About argenx
Biological Products, (No Diagnostic Substances)
The provided filing excerpt contains raw XBRL taxonomy identifiers and accounting data tags without any narrative corporate descriptions. Consequently, the excerpt does not disclose the company's business activities, main products, commercial services, operating segments, or customer base. The taxonomy references include equity items, share-based payment plans, and asset categories, but omit descriptive operational context.
Company profile, executives and historyargenx stock: common questions
What is argenx's stock price?
ARGX closed at $981.33 on Nov 12, 2026, up 0.38% on the day. Over the past 52 weeks it traded between $661.85 and $1072.75.
What is ARGX's P/E ratio?
ARGX trades at 50.1 times earnings, based on diluted earnings per share of $19.57 over fiscal 2025.
Does argenx pay a dividend?
No. argenx has not paid a cash dividend over the last twelve months.
How has ARGX stock performed over the past year?
Including dividends, ARGX returned +10.3% over the past year, against +12.0% for the S&P 500.
Who are argenx's competitors?
Companies most similar to argenx by business, industry and size include CKDXF, CLLS, RADX, PCT, GPLB.
See a number that looks wrong?